860695P
Avanti
Glucosyl(β) Sphingosine-d7
powder, Avanti Polar Lipids (860695P)
Sign Into View Organizational & Contract Pricing
All Photos(1)
D-glucosyl-β-1,1’-D-erythro-sphingosine-d7
C24H40D7NO7
Recommended Products
Assay
99% (TLC)
form
powder
packaging
pkg of 1 × 1 mg (860695P-1MG)
manufacturer/tradename
Avanti Polar Lipids (860695P)
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@](/C=C/CCCCCCCCCCC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])(O)[C@](N)([H])CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
General description
Glucosyl(β) Sphingosine-d7 is a deuterated derivative of glucosyl(β) sphingosine.
Biochem/physiol Actions
Glucosyl sphingosine acts as a biomarker for Gaucher′s disease.
Packaging
5 mL Amber Glass Screw Cap Vial
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Regulatory Information
新产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients
Testing, 8(11) (2013)
Glucosylsphingosine is a highly sensitive and specific biomarker for primary diagnostic and follow-up monitoring in Gaucher disease in a non-Jewish, Caucasian cohort of Gaucher disease patients
PLoS ONE, 8(11) (2013)
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service